Merck announced that it has signed a collaboration agreement with Biocartis for the development and commercialization of a new liquid biopsy RAS biomarker test for patients with metastatic colorectal cancer (mCRC). The test will be developed on Biocartis’ innovative, fully automated molecul ... more
Heinrich Emanuel Merck Award 2012 granted to Professor Aaron Wheeler
Merck announced that the 2012 Heinrich Emanuel Merck Award for Analytical Science will be given to Professor Wheeler from the University of Toronto for his development of a digital microfluidic method for the extraction and quantification of estrogen in 1-microliter samples of breast tissue homogenate, whole blood and serum. This method may be broadly applicable for diagnostics requiring frequent analysis of hormones in clinical samples, which are important markers for example in infertility or cancer. The award, endowed with € 15,000, will be presented to Professor Wheeler at Merck Millipore’s Technology Exposition in Bedford, Massachusetts, USA, on October 17, 2012.
“Professor Wheeler`s development of new analytical methods using digital microfluidic technology to overcome the limitations of conventional techniques in the extraction and quantification of estrogen is an outstanding scientific achievement with significant societal impact, for example in breast cancer diagnosis,” explained Professor Reinhard Niessner (Technical University of Munich, Germany), the head of the international jury for the Heinrich Emanuel Merck Award.
“By selecting Aaron Wheeler, we are recognizing a talented and very successful scientist. We are looking forward to his award lecture in October,” said Dr. Thomas Geelhaar, Chief Technology Officer Chemicals at Merck. “Thanks to his groundbreaking scientific approach, Professor Wheeler has helped to achieve tremendous advances in the research field of hormone analysis.”
Aaron R. Wheeler (37) is an Associate Professor at the University of Toronto, Department of Chemistry. The Wheeler research group is developing hybrid methods that rely on the unique advantages of microchannels and digital microfluidics for applications in the areas of chemistry, biology, and medicine.
Merck announced the completion of its $ 17 billion acquisition of Sigma-Aldrich, creating one of the leaders in the $ 130 billion global industry. The completion follows last week’s approval from the European Commission, which was the final antitrust condition required to close the Sigma-Al ... more
As part of the global strategic alliance between Merck and Pfizer to jointly develop and commercialize avelumab, an investigational immune checkpoint inhibitor, the companies have announced that they have a collaboration agreement in place with Dako, an Agilent Technologies company, for the ... more
Economical and reliable high-performance solution for analyzers with daily pure water needs of up to 3000 Liters daily more
The Milli-Q® Integral water purification system provides you with integrated, reliable lab-scale production of pure and ultrapure water more
The Scepter™, the industry's first handheld, automated cell counter represents a breakthrough for life science researchers more
The new Milli-Q Integral water purification system uses tap water to supply constant-quality Type II (pure) and Type I (ultrapure) water from a single water production unit. The Milli-Q Integral system produces pure and/or ultrapure water for needs ranging from 60 to 300 L/day. Separate Poi ... more
The Scepter™, the industry’s first handheld, automated cell counter represents a breakthrough for life science researchers. Unlike any other cell counter, this handheld device provides researchers with a simple and affordable automated option for counting cells and monitoring the health of ... more
Millitrack® Compliance software is included on all new Milli-Q® Advantage and Milli-Q® Integral water purification systems, and can be enabled using an activation key provided by Merck Millipore. In regulated laboratories, instrument qualification is a requirement. It is becoming increasing ... more